Religare Enterprises Q1 FY27 loss narrows to ₹96.2 crore

Overview: what Religare reported for Q1 FY27

Religare Enterprises Limited (NSE: RELIGARE, BSE: 532915) reported a narrower standalone net loss for the quarter ended June 30, 2026. The company said its standalone net loss stood at ₹96.2 crore, improving from a loss of ₹123.6 crore in the previous quarter. The improvement came alongside higher total income, which rose to ₹438.2 crore from ₹335.6 crore quarter-on-quarter. The board approved the unaudited standalone financial results on August 12, 2026, after a limited review by statutory auditors J C Bhalla & Co. The company also disclosed that total comprehensive income for the quarter was a loss of ₹96.2 crore.

Standalone quarterly performance: loss narrows as income rises

For the June 2026 quarter, Religare’s standalone net loss narrowed to ₹96.2 crore. In the immediately preceding quarter, the standalone net loss was ₹123.6 crore. The company reported total income of ₹438.2 crore in the June quarter, compared with ₹335.6 crore in the prior quarter. The disclosure indicates that the board considered and approved the unaudited results and the limited review report. The headline takeaway from the quarter is that the loss moderated while income moved up quarter-on-quarter. The company also aligned comprehensive income reporting, with total comprehensive income remaining a loss of ₹96.2 crore.

Board approval and audit review

Religare stated that its board approved the unaudited standalone financial results on August 12, 2026. The approval followed a limited review conducted by the statutory auditors, J C Bhalla & Co. The same regulatory communication framework also referenced consideration and approval of standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The disclosure was made under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This process is typically used to inform exchanges about board meetings and outcome-related decisions. In this case, the company’s communication focused on financial results approval and associated compliance steps.

Share warrants converted: equity allotment and funds received

During the quarter, Religare Enterprises converted share warrants into equity shares. The company said it received proceeds of ₹14.705 crore (₹1,470.5 lakh) from the conversion. The conversion involved allotment of 83,43,263 equity shares at a price of ₹235 per share. The disclosure presents this as a completed corporate action during the quarter, alongside the financial reporting update. The proceeds figure is stated as received, indicating the conversion was executed and funds were collected.

Trading window closure and reopening date

The company’s disclosure included an update on the trading window closure for dealing in Religare’s shares. It said the trading window was closed starting July 01, 2026, continuing a previous announcement dated June 30, 2026. The closure was to remain in effect until 48 hours after declaration of the unaudited financial results. With the board meeting dated August 12, 2026, the trading window was scheduled to reopen on August 14, 2026. This timeline is consistent with standard trading window restrictions around results announcements.

Market snapshot: price and move cited in the release

The shared market snapshot cited Religare Enterprises in the Finance - Investment sector and showed a price of ₹238.60 with a gain of ₹11.05 (up 4.86%) on BSE at 04:01 PM. Separately, the text also referenced a current share price of ₹235.7. These values reflect the prices cited in the provided information, and they indicate that the stock was trading higher at the time of the BSE snapshot referenced.

Earnings conference call scheduled for August 13

Religare announced an earnings conference call to discuss operational and financial performance for the quarter ended June 30, 2026 (Q1 FY27). The call was scheduled for Thursday, August 13, 2026, at 04:00 PM IST. Participants were required to pre-register using the link provided in the invitation, as per the announcement. The dial-in details included primary access numbers +91 22 6280 1102 and +91 22 7115 8003, along with toll-free numbers for the USA, UK, Singapore, Hong Kong, and other locations mentioned in the invitation.

Background signals: segments and earlier consolidated performance

In earlier segment reporting cited in the provided information, the Insurance segment (Care) recorded a Profit Before Tax (PBT) loss of ₹111.2 crore in Q3 FY26. In the same segment note, the Financial Services segment generated PBT of ₹8.5 crore on revenues of ₹143.1 crore. Separately, Religare reported a consolidated net loss of ₹76.54 crore for the quarter ended December 31, 2025, compared to a loss of ₹63.22 crore in the prior year period. The company also referenced that unaudited standalone and consolidated financial results for the quarter ended September 30, 2025 were approved by the board on November 13, 2025 and announced via newspaper publications on November 14, 2025.

Regulatory and corporate actions: demerger request rejected by RBI

The provided information also noted a regulatory setback: the Reserve Bank of India rejected the no-objection request for the proposed demerger scheme between Religare Enterprises and Religare Finvest Limited. This rejection was described as blocking the transfer of the demerged undertaking, despite earlier approvals from NSE and BSE. A table snippet in the provided information also referenced “Board Approval” dated February 14, 2026, marked as approved in relation to the event timeline.

Key numbers at a glance

What investors will track next

With the board approval dated August 12, 2026, the immediate follow-through event is the earnings call scheduled on August 13, 2026 at 4:00 PM IST. The company’s disclosures also highlight compliance steps such as trading window restrictions through August 14, 2026. Investors tracking Religare may also watch for further updates tied to consolidated performance, given that the board agenda included both standalone and consolidated unaudited results. Separately, developments around the proposed demerger scheme referenced in the RBI rejection note remain a key regulatory thread in the background.

Conclusion

Religare Enterprises reported a narrower standalone net loss of ₹96.2 crore for the June 2026 quarter as total income increased to ₹438.2 crore. The board approved the unaudited results on August 12, 2026 after a limited review by J C Bhalla & Co, and the company scheduled its Q1 FY27 earnings call for August 13, 2026. The trading window, closed since July 01, 2026, is slated to reopen on August 14, 2026 based on the stated timeline.